R
Robin DiFrancesco
Researcher at University at Buffalo
Publications - 57
Citations - 1150
Robin DiFrancesco is an academic researcher from University at Buffalo. The author has contributed to research in topics: Ritonavir & Lopinavir. The author has an hindex of 20, co-authored 57 publications receiving 1093 citations. Previous affiliations of Robin DiFrancesco include AIDS Clinical Trials Group & Silver Spring Networks.
Papers
More filters
Journal ArticleDOI
Interaction between buprenorphine and atazanavir or atazanavir/ritonavir
Elinore F. McCance-Katz,David E. Moody,Gene D. Morse,Qing Ma,Robin DiFrancesco,Gerald Friedland,Patricia Pade,Petrie M. Rainey +7 more
TL;DR: Drug interactions between buprenorphine and the protease inhibitors atazanavir and atazAnavir/ritonavir, an opioid partial agonist used to treat opioid dependence, and HIV therapeutics are examined.
Journal ArticleDOI
Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography–tandem mass spectrometry
Robin DiFrancesco,Valerie A. Frerichs,Julie Donnelly,Colleen E. Hagler,Jill Hochreiter,Kathleen M. Tornatore +5 more
TL;DR: A liquid chromatography-tandem mass spectrometry approach for the simultaneous analysis of several glucocorticoids, mycophenolic acid (MPA) and mycopenolic acid glucuronide (M PAG) was investigated, offering a versatile, unique method for multi-analyte immunosuppressive determinations during combination immunosppression.
Journal ArticleDOI
Inhibition of Atazanavir Oral Absorption by Lansoprazole Gastric Acid Suppression in Healthy Volunteers
Desiree L Tomilo,Patrick F. Smith,Abayomi B. Ogundele,Robin DiFrancesco,Charles S. Berenson,Ellana Eberhardt,Edward M. Bednarczyk,Gene D. Morse +7 more
TL;DR: Whether the pharmacokinetics of atazanavir, a protease inhibitor used to treat human immunodeficiency virus (HIV) infection, are altered by its coadministration with lansoprazole, a proton pump inhibitor is investigated.
Journal ArticleDOI
Quality Assurance Program for Clinical Measurement of Antiretrovirals: AIDS Clinical Trials Group Proficiency Testing Program for Pediatric and Adult Pharmacology Laboratories
TL;DR: The PT program results presented demonstrate excellent interlaboratory agreement for all antiretrovirals tested and provide support for the merger of plasma concentration data among laboratories for large clinical trials.
Journal ArticleDOI
Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma.
TL;DR: To facilitate the application of TDM, a method for the simultaneous determination of eight species has been developed and using reversed-phase high-performance liquid chromatography (RP-HPLC) was validated.